The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 17, 2015

Filed:

Nov. 06, 2009
Applicants:

Dario Norberto R. Carrara, Oberwil, CH;

Arnaud Grenier, Steinbrunn le haut, FR;

Inventors:

Dario Norberto R. Carrara, Oberwil, CH;

Arnaud Grenier, Steinbrunn le haut, FR;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 31/216 (2006.01); A61K 47/00 (2006.01); A61K 9/06 (2006.01); A61K 31/56 (2006.01); A61K 47/10 (2006.01); A61K 47/32 (2006.01); A61K 47/38 (2006.01);
U.S. Cl.
CPC ...
A61K 9/06 (2013.01); A61K 9/0014 (2013.01); A61K 31/216 (2013.01); A61K 31/56 (2013.01); A61K 47/10 (2013.01); A61K 47/32 (2013.01); A61K 47/38 (2013.01);
Abstract

The present invention relates generally to compositions or formulations for transdermal or transmucosal administration of anticholinergic agents such as oxybutynin. The invention utilizes a novel delivery vehicle and is a substantially malodorous-free and irritation free transdermal formulation which is substantially free of long chain fatty alcohols, long-chain fatty acids, and long-chain fatty esters. A method is disclosed for treating a subject for urinary incontinence with these formulations while reducing the incidences of peak concentrations of drug and undesirable side effects associated with oral anticholinergics.


Find Patent Forward Citations

Loading…